Apeloa Pharmaceutical Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000000Q45
  • SHE: 000739
CNY
25.32
1.32 (5.5%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
2,375.90
2,447.41
2,019.72
2,319.40
2,714.30
2,718.63
2,731.64
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,375.90
2,447.41
2,019.72
2,319.40
2,714.30
2,718.63
2,731.64
Raw Material Cost
1,711.06
1,773.35
1,430.75
1,824.62
2,011.70
2,117.18
2,154.38
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
7.98
7.95
7.18
6.24
5.67
4.68
5.92
Selling and Distribution Expenses
195.60
213.40
254.92
193.49
205.94
218.64
343.78
Other Expenses
11.17
10.28
11.78
11.34
12.34
13.95
14.67
Total Expenditure (Excl Depreciation)
2,026.38
2,097.52
1,810.64
2,137.72
2,346.66
2,480.02
2,650.76
Operating Profit (PBDIT) excl Other Income
349.5
349.90000000000003
209.1
181.70000000000002
367.59999999999997
238.6
80.9
Other Income
0.40
-10.17
112.41
32.56
26.58
82.30
129.00
Operating Profit (PBDIT)
494.52
480.04
422.74
362.31
531.77
467.46
334.34
Interest
7.98
7.95
7.18
6.24
5.67
4.68
5.92
Exceptional Items
8.17
-0.53
-0.02
0.06
-0.04
0.00
-0.50
Gross Profit (PBDT)
664.84
674.06
588.97
494.78
702.60
601.45
577.27
Depreciation
171.33
171.33
174.66
174.66
164.39
164.39
148.47
Profit Before Tax
323.37
300.23
240.89
181.47
361.67
298.40
179.45
Tax
50.52
48.54
36.57
43.43
46.62
48.90
21.99
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
273.35
249.02
190.41
137.22
314.50
248.55
161.47
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
273.35
249.02
190.41
137.22
314.50
248.55
161.47
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.07
0.26
0.08
-0.10
-0.00
0.03
-0.01
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
273.29
249.28
190.49
137.12
314.50
248.58
161.46
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
6,568.03
6,561.03
6,338.43
6,486.35
6,748.56
6,990.60
6,741.96
Earnings per share (EPS)
0.24
0.22
0.17
0.12
0.27
0.21
0.14
Diluted Earnings per share
0.24
0.22
0.17
0.12
0.27
0.21
0.14
Operating Profit Margin (Excl OI)
13.59%
13.03%
6.72%
6.69%
12.56%
8.12%
2.08%
Gross Profit Margin
20.82%
19.27%
20.57%
15.35%
19.38%
17.02%
12.0%
PAT Margin
11.51%
10.17%
9.43%
5.92%
11.59%
9.14%
5.91%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2026 is -2.92% vs 21.18% in Mar 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2026 is 9.63% vs 30.87% in Mar 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is 0.80% vs 57.98% in Mar 2026

stock-summary

Interest

QoQ Growth in quarter ended Jun 2026 is 0.00% vs 11.11% in Mar 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

Compare Quarterly Results Of Apeloa Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
2,375.90
0
2,375.90
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,375.90
0
2,375.90
Raw Material Cost
1,711.06
0
1,711.06
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
7.98
0
7.98
Selling and Distribution Expenses
195.60
0
195.60
Other Expenses
11.17
0.00
11.17
Total Expenditure (Excl Depreciation)
2,026.38
0
2,026.38
Operating Profit (PBDIT) excl Other Income
349.52
0.00
349.52
Other Income
0.40
0
0.40
Operating Profit (PBDIT)
494.52
0
494.52
Interest
7.98
0
7.98
Exceptional Items
8.17
0
8.17
Gross Profit (PBDT)
664.84
0
664.84
Depreciation
171.33
0
171.33
Profit Before Tax
323.37
0
323.37
Tax
50.52
0
50.52
Provisions and contingencies
0
0
0.00
Profit After Tax
273.35
0
273.35
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
273.35
0
273.35
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.07
0
-0.07
Other related items
0.00
0.00
0.00
Consolidated Net Profit
273.29
0
273.29
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
6,568.03
0
6,568.03
Earnings per share (EPS)
0.24
0
0.24
Diluted Earnings per share
0.24
0
0.24
Operating Profit Margin (Excl OI)
13.59%
0%
0.00
13.59%
Gross Profit Margin
20.82%
0%
0.00
20.82%
PAT Margin
11.51%
0%
0.00
11.51%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 237.59 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -2.92% vs 21.18% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -12.47% vs -15.98% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 27.33 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 9.63% vs 30.87% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -13.10% vs -17.43% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 49.41 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 0.80% vs 57.98% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -2.20% vs 0.36% in Jun 2025

Quarterly - Interest
Interest 0.80 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 0.00% vs 11.11% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 40.35% vs -18.57% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.59%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025

Footer loading